Trinity Capital Inc. Invests $50 Million in Nalu Medical for Chronic Pain Solutions
In a significant move to support innovative solutions in healthcare, Trinity Capital Inc. has announced a commitment of up to $50 million in growth funding for Nalu Medical, Inc. This investment aims to reinforce Nalu's efforts in developing advanced neurostimulation technologies tailored for patients grappling with chronic intractable neuropathic pain.
Nalu Medical, based in Carlsbad, California, focuses on creating minimally invasive treatments for individuals suffering from chronic pain conditions. At the core of Nalu's innovation is its proprietary device—the implanted pulse generator (IPG)—which utilizes sophisticated electrical impulse waveforms. This system modulates pain signals along the nerves before they can reach the brain, providing an effective solution for pain management. Notably, Nalu's device is battery-free and is designed for patient convenience, allowing users to control it directly from their smartphones.
Earlier this year, Nalu received approval from the FDA not only for the implantation of its system but significantly, for expanded labeling of its Peripheral Nerve Stimulation (PNS) therapy. Now, users can safely undergo whole-body MRI scans while benefitting from the device—an exciting development for the medical community and patients alike.
In discussing this partnership, Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital, expressed pride in supporting Nalu’s mission. Lake emphasized that Nalu is at the forefront of PNS technology and is making strides in transforming pain management through its cutting-edge solutions and solid clinical data.
On the other hand, Tom West, President and CEO of Nalu Medical, highlighted the importance of this funding for the company's future endeavors. He cited the financial flexibility gained from Trinity's involvement as crucial for expanding the commercial rollout of their next-generation Therapy Disc. Furthermore, West referenced their recent achievement in compiling what is viewed as one of the largest long-term real-world data sets for a permanent PNS device, providing valuable insights into long-term pain relief reliability across diverse patient demographics.
Trinity Capital Inc. is renowned for being a leading alternative asset manager. Its primary goal is to deliver consistent returns to investors by offering access to private credit markets. Trinity strategically structures investments to support growth-oriented businesses. They operate through five core business verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset-Based Lending, and Life Sciences. Based in Phoenix, Arizona, Trinity Capital has established a strong presence across the United States and Europe, ensuring they are well-positioned to assist innovative companies seeking tailored debt solutions.
With Nalu Medical’s commitment to addressing significant unmet needs in chronic neuropathic pain, and the financial backing from Trinity Capital Inc., the landscape of pain management may witness a revolutionary transformation. As both companies move forward with their respective ambitions, the commitment to enhancing patient care through advanced technology remains at the heart of their collaboration. Pain management solutions like those developed by Nalu could significantly alter the treatment landscape for millions of individuals affected by chronic pain, promising a new era of hope and relief.
For more insight on Trinity Capital or Nalu Medical, visit their websites at trinitycapital.com and nalumed.com respectively. Stay updated on industry news through professional networks like LinkedIn and follow them for further announcements on groundbreaking developments in the medical field.
The Role of Nalu Medical
Nalu Medical, based in Carlsbad, California, focuses on creating minimally invasive treatments for individuals suffering from chronic pain conditions. At the core of Nalu's innovation is its proprietary device—the implanted pulse generator (IPG)—which utilizes sophisticated electrical impulse waveforms. This system modulates pain signals along the nerves before they can reach the brain, providing an effective solution for pain management. Notably, Nalu's device is battery-free and is designed for patient convenience, allowing users to control it directly from their smartphones.
Earlier this year, Nalu received approval from the FDA not only for the implantation of its system but significantly, for expanded labeling of its Peripheral Nerve Stimulation (PNS) therapy. Now, users can safely undergo whole-body MRI scans while benefitting from the device—an exciting development for the medical community and patients alike.
A Reliable Partnership
In discussing this partnership, Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital, expressed pride in supporting Nalu’s mission. Lake emphasized that Nalu is at the forefront of PNS technology and is making strides in transforming pain management through its cutting-edge solutions and solid clinical data.
On the other hand, Tom West, President and CEO of Nalu Medical, highlighted the importance of this funding for the company's future endeavors. He cited the financial flexibility gained from Trinity's involvement as crucial for expanding the commercial rollout of their next-generation Therapy Disc. Furthermore, West referenced their recent achievement in compiling what is viewed as one of the largest long-term real-world data sets for a permanent PNS device, providing valuable insights into long-term pain relief reliability across diverse patient demographics.
Trinity Capital: A Trustworthy Ally
Trinity Capital Inc. is renowned for being a leading alternative asset manager. Its primary goal is to deliver consistent returns to investors by offering access to private credit markets. Trinity strategically structures investments to support growth-oriented businesses. They operate through five core business verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset-Based Lending, and Life Sciences. Based in Phoenix, Arizona, Trinity Capital has established a strong presence across the United States and Europe, ensuring they are well-positioned to assist innovative companies seeking tailored debt solutions.
The Future of Pain Management
With Nalu Medical’s commitment to addressing significant unmet needs in chronic neuropathic pain, and the financial backing from Trinity Capital Inc., the landscape of pain management may witness a revolutionary transformation. As both companies move forward with their respective ambitions, the commitment to enhancing patient care through advanced technology remains at the heart of their collaboration. Pain management solutions like those developed by Nalu could significantly alter the treatment landscape for millions of individuals affected by chronic pain, promising a new era of hope and relief.
For more insight on Trinity Capital or Nalu Medical, visit their websites at trinitycapital.com and nalumed.com respectively. Stay updated on industry news through professional networks like LinkedIn and follow them for further announcements on groundbreaking developments in the medical field.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.